RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/50209
https://w3id.org/ripe/ripe-kg/retraction-notice/50209
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prism:doi |
10.1016/j.jns.2023.122818 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prism:publicationDate |
2024-01-09 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prism:publicationName |
Journal of the Neurological Sciences |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
dcterms:publisher |
ripekg:publisher/RIPEP89ABFFE2696381B7Elsevier |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
dcterms:title |
Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1016%2Fs0022-510x%2803%2900101-1 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
owl:Thing |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
owl:sameAs |
https://semopenalex.org/work/W4389560194 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA02C7C24523188961 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA02C7C24523188961 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripe:concerns |
ripekg:author/RIPEAU6F968D13B49DFACEYoshihiro Sato |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripe:concerns |
ripekg:author/RIPEAUFA3D5EA9098F1CDDKei Satoh |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripe:concerns |
ripekg:work/10.1016%2Fs0022-510x%2803%2900101-1 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripe:rationale |
Concerns/Issues About Authorship/Affiliation;Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Investigation by Journal/Publisher;Unreliable Results and/or Conclusions |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
ripe:retractionWatchRecordId |
50209 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-3 |
ripekg:retraction-notice/50209Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-3 |